Inside Andreas Strüngmann's Fortune: Andreas Strüngmann's Assets & Salary ( Updated) Net Worth 2026: Career Earnings & Assets

As one of the most talked-about figures, Andreas Strüngmann has built a significant fortune. Our team analyzed the latest data to provide a clear picture of their income.

What is Andreas Strungmann's Net Worth?

Andreas Strungmann is a German pharmacist who has a net worth of $3.6 billion. Born in 1950, Andreas and his twin brother, Thomas, made their fortune as founders of Hexal AG, one of the leading generic producers in Germany. The medical doctor Andres left his medical practice in Africa; and again together with his brother, he founded generic drug producer Hexal AG in 1986.

Two decades later, the brothers sold the company and their 68% share of Eon Labs of the U.S. to Novartis, which makes Sandoz the biggest generic drug company. Since then, through their Santo Holding, the twin duo has been investing in biotech sector focused on cancer research. Moreover, Andreas accepted an executive position at Sandoz at the age of 56.

Ultimately, Andreas Strüngmann's financial journey is a testament to their success.

Disclaimer: All net worth figures are estimates based on public data.